 |
|
Chorionic Gonadotropin in Weight ControlA Double-Blind Crossover Study
Lt Col Robert L. Young, MC;
Robert J. Fuchs, MS;
Myron J. Woltjen, MD
JAMA. 1976;236(22):2495-2497.
Abstract
Two hundred two patients participated in a double-blind random crossover study of the effectiveness of human chorionic gonadotropin (HCG) vs placebo in a weight reduction program. Serial measurements were made of weight, skin-fold thickness, dropout rates, reasons for dropping out, and patient subjective response. There was no statistically significant difference between those receiving HCG vs placebo during any phase of this study (P>.1).
(JAMA 236:2495-2497, 1976)
Author Affiliations
USAF
From the Department of Medicine, Endocrine Service, Wilford Hall USAF Medical Center Lackland Air Force Base, Tex (Lt Col Young), Biometrics Division, Brooks Air Force Base, Tex (Mr Fuchs), and USAF Hospital, Dyess Air Force Base, Tex (Dr Woltjen). Dr Woltjen is now in private practice in Abilene, Tex.
Footnotes
Reprint requests to SGHME, Department of the Air Force, Wilford Hall USAF Medical Center (AFSC), Lackland Air Force Base, TX 78236 (Lt Col Young).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Recombinant Human Chorionic Gonadotropin on Muscle Strength and Physical Function and Activity in Older Men with Partial Age-Related Androgen Deficiency
Liu et al.
J. Clin. Endocrinol. Metab. 2002;87:3125-3135.
ABSTRACT
| FULL TEXT
Current and Potential Drugs for Treatment of Obesity
Bray and Greenway
Endocr. Rev. 1999;20:805-875.
ABSTRACT
| FULL TEXT
Survey of Very-Low-Calorie Weight Reduction Diets: I. Novelty Diets
Newmark and Williamson
Arch Intern Med 1983;143:1195-1198.
ABSTRACT
|
